Cargando…
A model of metformin mitochondrial metabolism in metachromatic leukodystrophy: first description of human Schwann cells transfected with CRISPR-Cas9
Metachromatic leukodystrophy is a neurological lysosomal deposit disease that affects public health despite its low incidence in the population. Currently, few reports are available on pathophysiological events related to enzyme deficiencies and subsequent sulfatide accumulation. This research aims...
Autores principales: | Sanchez-Álvarez, Nayibe Tatiana, Bautista-Niño, Paula Katherine, Trejos-Suárez, Juanita, Serrano-Díaz, Norma Cecilia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256087/ https://www.ncbi.nlm.nih.gov/pubmed/35857900 http://dx.doi.org/10.1098/rsob.210371 |
Ejemplares similares
-
Intrathecal baclofen in metachromatic leukodystrophy
por: van der Veldt, Nikki, et al.
Publicado: (2018) -
Developing therapeutic approaches for metachromatic leukodystrophy
por: Patil, Shilpa A, et al.
Publicado: (2013) -
Diffusion tensor imaging in metachromatic leukodystrophy
por: van Rappard, Diane F., et al.
Publicado: (2018) -
Understanding caregiver descriptions of initial signs and symptoms to improve diagnosis of metachromatic leukodystrophy
por: Eichler, F., et al.
Publicado: (2022) -
Acetobacter indonesiensis Bacteremia in Child with Metachromatic Leukodystrophy
por: Kohlmann, Rebekka, et al.
Publicado: (2016)